A detailed history of Axxcess Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 27,463 shares of NVO stock, worth $2.97 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
27,463
Previous 27,715 0.91%
Holding current value
$2.97 Million
Previous $3.96 Million 17.34%
% of portfolio
0.08%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $30,005 - $36,645
-252 Reduced 0.91%
27,463 $3.27 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $470,470 - $563,252
3,834 Added 16.05%
27,715 $3.96 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $727,840 - $968,837
-7,128 Reduced 22.99%
23,881 $3.07 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $299,066 - $359,268
3,407 Added 12.34%
31,009 $3.21 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.45 Million - $3.19 Million
15,991 Added 137.72%
27,602 $2.51 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $523,780 - $579,758
3,358 Added 40.69%
11,611 $1.88 Million
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $95,549 - $114,899
722 Added 9.59%
8,253 $1.31 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $344,670 - $454,844
3,361 Added 80.6%
7,531 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $397,317 - $487,598
4,170 New
4,170 $416,000
Q1 2022

Aug 11, 2022

SELL
$93.1 - $112.54 $220,647 - $266,719
-2,370 Closed
0 $0
Q4 2021

Aug 11, 2022

BUY
$95.88 - $117.08 $227,235 - $277,479
2,370 New
2,370 $265,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.